Microfluidic structures for biomedical applications
10265698 ยท 2019-04-23
Assignee
- The Charles Stark Draper Laboratory, Inc. (Cambridge, MA)
- The Brigham And Women's Hospital, Inc. (Boston, MA)
- The Massachusetts Institute Of Technology (Cambridge, MA)
Inventors
- Jeffrey T. Borenstein (Newton, MA)
- Eli J. Weinberg (Needham, MA, US)
- James C. Hsiao (Watertown, MA, US)
- Ahmad S. KHALIL (Boston, MA, US)
- Malinda M. Tupper (Somerville, MA, US)
- Guillermo Garcia-Cardena (Cambridge, MA, US)
- Peter MACK (Chapel Hill, NC, US)
- Sarah L. Tao (Cambridge, MA, US)
Cpc classification
B29L2031/753
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/12
PERFORMING OPERATIONS; TRANSPORTING
B81B2201/058
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502707
PERFORMING OPERATIONS; TRANSPORTING
Y10T29/49155
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10T428/139
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B29C59/02
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/12
PERFORMING OPERATIONS; TRANSPORTING
Y10T156/1039
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B81C1/00119
PERFORMING OPERATIONS; TRANSPORTING
Y10T29/49156
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B81C99/0085
PERFORMING OPERATIONS; TRANSPORTING
Y10T29/49401
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B29C33/3857
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
International classification
B01L99/00
PERFORMING OPERATIONS; TRANSPORTING
B81C99/00
PERFORMING OPERATIONS; TRANSPORTING
B81C1/00
PERFORMING OPERATIONS; TRANSPORTING
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
B29C59/02
PERFORMING OPERATIONS; TRANSPORTING
Abstract
Microfluidic structures featuring substantially circular channels may be fabricated by embossing polymer sheets.
Claims
1. A microfluidic device, comprising: (a) a plurality of microfluidic structures, each structure comprising a polymer scaffold defining at least one channel therein, the plurality of microfluidic structures being stacked so as to form a stacked microfluidic assembly that defines a front surface comprising inlets of the channels; and (b) a microfluidic header comprising at least one polymer scaffold that defines a network of channels comprising a branching structure, wherein: the branching structure includes a plurality of branches and gradual transitions in channel geometries at the branches, the microfluidic header further comprises multiple levels of branching within the branching structure, and the microfluidic header is coupled to the front surface of the stacked microfluidic assembly such that outlets of the microfluidic header are aligned with the inlets of the stacked microfluidic assembly to fluidically couple respective channels in the plurality of microfluidic structures of the stacked microfluidic assembly to channels in the network of channels of the microfluidic header.
2. The microfluidic device of claim 1, wherein the microfluidic header comprises a plurality of polymer scaffolds, each polymer scaffold defining a network of channels therein.
3. The microfluidic device of claim 1, wherein at least a portion of at least one channel is characterized by a substantially circular cross section and a diameter less than 300 micrometers.
4. The microfluidic device of claim 1, wherein a primary plane of the network of channels is rotated with respect to primary planes of the plurality of microfluidic structures.
5. The microfluidic device of claim 4, wherein the primary plane of the network of channels is rotated about 90 degrees with respect to the primary planes of the plurality of microfluidic structures.
6. The microfluidic device of claim 1, wherein a first polymer scaffold of the at least one polymer scaffold defines a first half of a cross section of the network of channels and a second polymer scaffold of the at least one polymer scaffold defines a second half of the cross section of the network of channels.
7. The microfluidic device of claim 1, wherein the plurality of branches comprise bifurcations of the network of channels.
8. The microfluidic device of claim 1, wherein at least a portion of the network of channels is characterized by a substantially circular cross section.
9. The microfluidic device of claim 1, wherein one or more of the channels in the network of channels comprises a gradually changing diameter over a length thereof.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The foregoing and other objects, aspects, features, and advantages of the invention will become more apparent and may be better understood by referring to the following description taken in conjunction with the accompanying drawings, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
DESCRIPTION
(26) Described herein are various embodiments of microfluidic structures and three-dimensional microfluidic devices for biomedical applications. Computational models for microvascular networks, precise microfluidic fabrication technologies, and an endothelial cell model system may be integrated to clearly establish functional cell phenotype in a true three-dimensional construct. This technology may be used to manufacture devices for in-vitro applications, including: fundamental vascular biology research; investigations of clotting, inflammation, plaque formation, and other pathologic states of vasculature; and drug discovery and drug safety testing. Moreover, the technology may be translated into precision three-dimensional biodegradable scaffolds integrated with co-culture models and matrix materials suitable for tissue engineering applications, such as the development of wearable or implantable devices that incorporate vascular access and a microcirculation.
(27) In accordance with various embodiments of the invention, microfluidic structures containing substantially cylindrical microchannels of vascular-like geometry, with diameters ranging from approximately 5 microns to more than 10 mm and with lengths ranging from approximately 100 microns to several centimeters, may be fabricated. Aspects of the vascular-like geometry may include smooth microchannel walls, substantially circular channel cross-sections, continuous changes in channel diameters, and gradual transitions between channels at bifurcations. These features allow for smooth flow paths throughout the entirety of the channel network.
(28) Microfluidic structures may be constructed using scaffolding materials compatible with the seeding, expansion, and sustainment of functional vascular cells, including endothelial cells and smooth muscle cells. In various embodiments of the invention, methods for fabricating such microfluidic scaffolds involve fabricating master molds that mimic the geometry of microvascular networks and embossing these master molds into a well-established substrate for tissue culture. Certain methods may produce cylindrical geometries suitable for microvessels at diameters as small as tens of microns, distinguishing them from other common microfluidic fabrication techniques such as SU-8 photolithography or Deep Reactive Ion Etching.
(29) The flow chart depicted in
(30) In step 102, the photomask is used to pattern a substrate, typically a silicon wafer. Patterning may generally involve several lithography, chemical development, etching, baking, and lift-off steps. The particular process sequence involved depends on the ensuing master mold fabrication steps, and is explained in detail further below in the context of specific methods.
(31) In some embodiments, illustrated by the left-hand branch of the flow chart depicted in
(32) The electroplated master mold may be used directly to hard emboss substantially half-cylindrical features into a polymer sheet, such as a polycarbonate or polystyrene sheet (step 106). For cell cultures of numerous cell types, tissue culture grade polystyrene provides a well-established platform. In an exemplary hard embossing technique that is robust, reproducible, and high-precision, polystyrene sheets from Plaskolite, Inc. (040 Clear UVF Styrene), cut to the appropriate size, are hard embossed using a metal-plated silicon mold as described above. More specifically, the silicon mold and polystyrene sheet are sandwiched between two pieces of Kapton film (Fralock Inc.) in an embossing apparatus, which allows for precise control of the temperature and pressure. The temperature of the apparatus may be raised to 130 C., and the chamber evacuated, causing the piston of the embosser to exert a pressure of 25 inches Hg on the mold and polystyrene substrate. The temperature may be maintained at 130 C. for 15 minutes, then the apparatus cooled to approximately 40 C. The mold and substrate may then be removed from the embosser and separated to form a free-standing polystyrene device with rounded microchannels. Deeper channels that allow for incorporation of flexible tubing may be created by attaching metal tubing at the ends of the microchannels. An example of an embossed polystyrene part is shown in
(33) In an alternative embodiment, the master mold may be used to emboss a transfer polymer mold (step 106), resulting in a lowered relief, and the transfer polymer mold used to emboss a second transfer polymer mold (step 106), resulting in a raised relief. Finally, the second transfer polymer mold may be used to emboss the polystyrene sheet (step 106). This method is advantageous in that it avoids the repeated use of the electroplated master molds, which can be fragile and delaminate over time and temperature cycles. A transfer mold is often more robust since it is one solid piece, rather than a composite of a substrate with an electroplated metal pattern on top. Suitable materials for both the first and second transfer mold are hard polymers that will withstand temperature and maintain precise features over time and temperature cycling, such as, e.g., polyurethane, polystyrene, or polypropylene.
(34) Alternatively, and with reference to the right-hand branch of the flow chart depicted in
(35) The pattern etched into the silicon wafer may be transferred to a master polymer mold, such as, for example, a PDMS mold or a polyurethane mold, thereby producing rounded raised structures similar to those of the electroplated mold (step 110). The master polymer mold may then be used to soft-emboss a polymer sheet, such as a polystyrene sheet, thereby creating rounded microchannel portions (step 112). In this case, the polystyrene sheet may be heated to a higher temperature (150 C.) to allow it to form more readily around the soft polymer mold. In various embodiments, producing a polymer copy of the etched silicon wafer is preferable over using the etched silicon wafer directly since polymers may exhibit material properties advantageous for biomedical applications, including transparency, low material cost, biocompatibility, and, in some cases, biodegradability. An exemplary silicon wafer, polymer (e.g., PDMS) transfer mold, and embossed polystyrene part created from this process are depicted in
(36) In an optional step 114, the channel portions in the polystyrene surface may be treated chemically, e.g., with an oxygen plasma using a Technics Microstripper with a setting of 100 mW and 100 mTorr O.sub.2 pressure for one minute, so that they become more hydrophilic and friendly to cell adhesion. Two corresponding embossed, treated surfaces may then be placed in contact, and the channels portions aligned with the aid of an optical microscope such as to form substantially cylindrical channels (step 116). Flexible silastic tubing (Dow Corning Inc.) may be cut and placed in the deeper channels designed for tubing connections. The two sheets may be thermally bonded in the embossing apparatus at 90 C. for 30 minutes. The flexible tubing may also be sealed in place during bonding, creating a seamless interface for injection of cells. An exemplary microfluidic structure, fabricated by hard embossing an electroplated master mold into two polystyrene sheets, is depicted in
(37) In step 118, the microfluidic structure may be plated with cells of various types, e.g., with endothelial cells. Tissue culture grade polystyrene, which serves as the industry standard for cell and tissue arrays for high-throughput screening and other laboratory applications, is highly suitable for establishing a robust functional phenotype.
(38) A. Electroplating Methods for Fabricating Master Molds
(39) Various electroplating methods may be employed to fabricate master molds with inverse channel portions that feature substantially semicircular cross sections, gradually varying diameters, and/or smooth bifurcations.
(40) In the subsequent steps, the insulating layer may be patterned according to the desired microfluidic structure, utilizing the photomask fabricated in step 100. In one embodiment, the insulator-coated wafer is covered with a specialized lift-off resist (e.g., Microchem, Corp. LOR series) and the photoresist AZ1518 (step 602). The photomask is then placed onto the wafer, e.g., using a contact aligner (e.g., Karl Suss MA-6), for the subsequent lithography step 604. After illumination, the photoresist and lift-off resist may be developed using diluted AZ400K and MF319, respectively (step 606). In step 608, the seed metal for electroplating is deposited. Suitable seed metals include chrome, gold, titanium, tungsten, and platinum, as well as combinations thereof, such as chrome-gold (e.g., 1000 A Cr/3000 A Au) or titanium-tungsten. In some embodiments, the seed metal layer includes an adhesion layer of chrome, titanium, or tungsten-titanium, and a top metal layer of gold, platinum, or copper. The seed metal may be deposited in a sputterer (e.g., Mill Lane DC Magnetron Sputterer) or in an evaporator (e.g., Denton E-Beam Evaporator). Lift-off (step 610) may be achieved by ultrasonically agitating the wafer in a solvent. The resulting structure 640, depicted in
(41) With reference to
(42) In one embodiment, the metal electroplating begins immediately in regions for which the metal pattern is directly connected to the anode, but is delayed in other regions by the presence of the gaps breaking the connection between the anode and the exposed seed metal. The length of these gaps governs the delay time prior to the start of electroplating the metal onto the next level of microchannels with the network design. For instance, a gap of 100 microns introduces a time delay such that the largest ridges are 100 microns taller than the next level structures. By varying the gaps in a systematic fashion, an entire range of microvessel diameters may be achieved on embossed layers. For example,
(43) An alternative method, which may reproducibly achieve nearly circular geometries, is an electroplating process known as a buried electrode process, depicted in
(44) An exemplary patterned structure 740, depicted in
(45) In general, the shape and smoothness of the electroplated relief structures depend on the dimensions of the wafer pattern, as well as on various electroplating process parameters, including the electroplated material, the current density, the anode configuration, and the bath concentration and agitation. Nearly perfectly inverse circular geometries in master molds may be achieved in a commercial copper bath solution (e.g., Technic, Inc. Copper Bath RTU) without agitation at a current density in the range from 5.5 mA/cm.sup.2 to 7.75 mA/cm.sup.2. To obtain uniform current densities, an anode in spiral wire configuration may be employed. The resulting plating rate is about 14 m/hour. Starting with feature widths of 50 m in the patterned wafer, the height of the inverse channel portions approaches the width at a diameter of the inverse channel portion of about 200 m. Using the ratio of the largest to the smallest diameter of realistic channels as a measure of the degree of circularity, ratios of less than 1.3 can be achieved.
(46) The buried electrode wafer depicted in
(47) In order to employ the buried electrode process and to achieve inverse channel portions with varying diameter, the advantageous properties of the buried electrode and the patterned gap process can be combined in a hybrid method illustrated in
(48) An exemplary wafer 840, patterned according to the method shown in
(49) B. Integrated Three-dimensional Microfluidic Networks
(50) Microfluidic scaffolds having two layers of polymer sheets joined together typically form a two-dimensional flow network. In order to build a three-dimensional flow network, several such two-dimensional structures may be combined. For example, as illustrated in
(51) The header 906 may be fabricated using stereolithography (SLA) technology, or employing the techniques described earlier. For example,
(52) In one embodiment, the microchannel flow network of the headers 906 is rotated with respect to the flow networks in the stacked structure 902, and aligned with the outlets 904 in a front surface 910 of the stacked structure 902 that arises from a flush arrangement of the layers 900. If the outlets 904 are placed along a straight line, as depicted, the header 906 need only contain a single channel flow network. Generally, structures 902 may contain different channel flow networks, whose outlets form a two-dimensional pattern in the front surface 908. Fluidic connections between the layers 900 may then be achieved with a header 906 that comprises several layers with microchannel networks itself.
(53) A photograph of an exemplary assembly of a three-dimensional flow network is shown in
(54) C. Biomedical Applications
(55) Establishment of a robust functional phenotype for endothelial cells in three-dimensional microfluidic constructs typically requires exquisite control over numerous parameters associated with the cell microenvironment. Among these are surface chemical interactions between the cultured endothelial layer and the walls of the scaffold, and the stability of the surface over time. In addition, the mechanical forces present must be well-controlled and stable over time and as a function of cell seeding and local flow conditions.
(56) As described herein, microfluidic devices according to various embodiments provide microchannels with smooth walls, substantially circular cross sections, and gradually varying diameters. The combination of these features results in smooth transitions at bifurcations. By contrast, bifurcations of channels with rectangular cross sections typically result either in a change of the channel aspect ratio, i.e., the ratio of channel width to channel height, or, if the area of the channel cross section changes at the bifurcation while the aspect ratio remains constant, in abrupt changes in channel height. Both changes in the aspect ratio and the sharp corners associated with abrupt changes in channel dimension typically result in flow turbulences. Devices manufactured in accordance with certain embodiments of the present invention, on the other hand, feature smooth flow paths and, as a result, well-controlled forces, throughout the entirety of the channel network.
(57) Chemical interactions between endothelial cells and the channels influence the ability of the cells to attach as a confluent monolayer to the network channel walls and maintain viability under normal culture conditions. As depicted in
(58) Open polystyrene half-channels having diameters of about 200 m, generated with the above-described electroplating fabrication approach, may be plated for 18 hours with HUVEC and assessed for monolayer formation and cell viability. As shown in
(59) Several advantages to the approaches described herein include the ability to produce vascular networks having vessels with substantially cylindrical geometries, and to construct smooth transitions at vessel bifurcations and vessel diameter changes in a manner similar to healthy physiologic structures. Once such a healthy physiologic structure has been manufactured as described herein, a specific geometry associated with disease or pathology may be introduced into a single one of the vessels and studied in isolation. For example, a rectangular geometry, a sharp angle or bend, a dead space, and/or a sudden expansion or contraction at a vessel bifurcation or at a dimensional change in the vessel may be introduced therein to approximate an atherosclerotic or other cardiovascular condition. In such a fashion, a disturbed flow condition associated with, for example, thrombus formation, plaque formation, or an inflammatory response may be studied in isolation and in a controlled fashion at that single diseased or pathologic structure.
(60) Having described certain embodiments of the invention, it will be apparent to those of ordinary skill in the art that other embodiments incorporating the concepts disclosed herein may be used without departing from the spirit and scope of the invention. For example, the electroplating methods described may also be applied to the optimization of inverse channel geometries with non-semicircular cross sections. Accordingly, the described embodiments are to be considered in all respects as only illustrative and not restrictive.